The role of [18F]FMISO PET in resolving Dotatate uptake in a doNUT-like pattern in neuroendocrine neoplasms

orthern Sydney Local Health District0 个研究点目标入组 10 人开始时间: 2018年11月8日最近更新: 2018年11月19日

适应症

试验速览

暂无简介。

•1) Patients 18 years of age or older with metastatic neuroendocrine neoplasm (NEN) and histological confirmation who have undergone PET scans at Royal North Shore Hospital
•2) Patients identified by the nuclear medicine physicians as having a lesion with 68Ga-DOTATATE PET (DOTA) avidity on the periphery but not the centre of the lesion (i.e. lack of avidity in the hole of the donut-like tumour).

•1) Patients who have not received a PET scan at RNSH
•2) Patients without a histological diagnosis of metastatic NEN
•3) Inability to lie in a supine position on the PET scanning bed for 15 minutes;
•4) Subjects who required sedation for their baseline clinical PET scan;
•5) Renal failure requiring haemo- or peritoneal dialysis;
•6) Substance abuse, medical, psychological or social conditions that in the opinion of the investigator may interfere with the patient’s participation in the study or evaluation of the study results;

发起方

orthern Sydney Local Health District